← FDA Drug Approvals (Drugs@FDA)

BETAINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2021-11-23

Drug application

FDA Application #

ANDA214864

Application type

Abbreviated New Drug Application (Generic)

Brand name

BETAINE

Generic name

Betaine

Active ingredients

BETAINE

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

First approval

2021-11-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown